BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ratajczak HV. Theoretical aspects of autism: biomarkers--a review. J Immunotoxicol 2011;8:80-94. [PMID: 21299356 DOI: 10.3109/1547691X.2010.538749] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Randolph-Gips M, Srinivasan P. Modeling autism: a systems biology approach. J Clin Bioinforma. 2012;2:17. [PMID: 23043674 DOI: 10.1186/2043-9113-2-17] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
2 Voineagu I, Yoo HJ. Current progress and challenges in the search for autism biomarkers. Dis Markers 2013;35:55-65. [PMID: 24167349 DOI: 10.1155/2013/476276] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
3 Smirnova L, Hogberg HT, Leist M, Hartung T. Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities. ALTEX 2014;31:129-56. [PMID: 24687333 DOI: 10.14573/altex.1403271] [Cited by in Crossref: 23] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
4 Shomrat T, Nesher N. Updated View on the Relation of the Pineal Gland to Autism Spectrum Disorders. Front Endocrinol (Lausanne) 2019;10:37. [PMID: 30804889 DOI: 10.3389/fendo.2019.00037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
5 Bernie C, Williams K, O'Connor B, Rogers S, May T. Referral, Assessment and Use of Screening Measures Related to Autism Spectrum Disorder at a Tertiary Hospital Setting. J Autism Dev Disord 2021;51:2673-85. [PMID: 33034784 DOI: 10.1007/s10803-020-04725-8] [Reference Citation Analysis]
6 Tirouvanziam R, Obukhanych TV, Laval J, Aronov PA, Libove R, Banerjee AG, Parker KJ, O'Hara R, Herzenberg LA, Herzenberg LA, Hardan AY. Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders. J Autism Dev Disord 2012;42:827-36. [PMID: 21713591 DOI: 10.1007/s10803-011-1314-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
7 Kharrat N, Abdelhedi R, Gtif I, Ayadi I, Rizzo R, Bortolotti D, Abdelmoula NB, Ghribi F, Rebai A, Zidi I. Non-classical human leukocyte antigen class I in Tunisian children with autism. Cent Eur J Immunol 2020;45:176-83. [PMID: 33456328 DOI: 10.5114/ceji.2020.97906] [Reference Citation Analysis]
8 Corley MJ, Meyza KZ, Blanchard DC, Blanchard RJ. Reduced sulfate plasma concentrations in the BTBR T+tf/J mouse model of autism. Physiol Behav 2012;107:663-5. [PMID: 22538115 DOI: 10.1016/j.physbeh.2012.04.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
9 Ratajczak HV, Sothern RB. Measurement in saliva from neurotypical adults of biomarkers pertinent to autism spectrum disorders. Future Sci OA 2015;1:FSO70. [PMID: 28031921 DOI: 10.4155/fso.15.70] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
10 Machado C, Estévez M, Leisman G, Melillo R, Rodríguez R, DeFina P, Hernández A, Pérez-Nellar J, Naranjo R, Chinchilla M, Garófalo N, Vargas J, Beltrán C. QEEG spectral and coherence assessment of autistic children in three different experimental conditions. J Autism Dev Disord 2015;45:406-24. [PMID: 24048514 DOI: 10.1007/s10803-013-1909-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
11 Castejon AM, Spaw JA, Rozenfeld I, Sheinberg N, Kabot S, Shaw A, Hardigan P, Faillace R, Packer EE. Improving Antioxidant Capacity in Children With Autism: A Randomized, Double-Blind Controlled Study With Cysteine-Rich Whey Protein. Front Psychiatry 2021;12:669089. [PMID: 34658941 DOI: 10.3389/fpsyt.2021.669089] [Reference Citation Analysis]
12 Goldani AA, Downs SR, Widjaja F, Lawton B, Hendren RL. Biomarkers in autism. Front Psychiatry 2014;5:100. [PMID: 25161627 DOI: 10.3389/fpsyt.2014.00100] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 10.6] [Reference Citation Analysis]
13 Zwaigenbaum L, Bauman ML, Fein D, Pierce K, Buie T, Davis PA, Newschaffer C, Robins DL, Wetherby A, Choueiri R, Kasari C, Stone WL, Yirmiya N, Estes A, Hansen RL, Mcpartland JC, Natowicz MR, Carter A, Granpeesheh D, Mailloux Z, Smith Roley S, Wagner S. Early Screening of Autism Spectrum Disorder: Recommendations for Practice and Research. PEDIATRICS 2015;136:S41-59. [DOI: 10.1542/peds.2014-3667d] [Cited by in Crossref: 138] [Cited by in F6Publishing: 64] [Article Influence: 19.7] [Reference Citation Analysis]
14 Anderson GM. Autism biomarkers: challenges, pitfalls and possibilities. J Autism Dev Disord 2015;45:1103-13. [PMID: 25193140 DOI: 10.1007/s10803-014-2225-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
15 Skonieczna-Żydecka K, Jamioł-Milc D, Borecki K, Stachowska E, Zabielska P, Kamińska M, Karakiewicz B. The Prevalence of Insomnia and the Link between Iron Metabolism Genes Polymorphisms, TF rs1049296 C>T, TF rs3811647 G>A, TFR rs7385804 A>C, HAMP rs10421768 A>G and Sleep Disorders in Polish Individuals with ASD. Int J Environ Res Public Health 2020;17:E400. [PMID: 31936202 DOI: 10.3390/ijerph17020400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhang‐james Y, Buitelaar JK, Rooij D, Faraone SV; The ENIGMA‐ASD Working Group. Ensemble classification of autism spectrum disorder using structural magnetic resonance imaging features. JCPP Advances 2021;1. [DOI: 10.1002/jcv2.12042] [Reference Citation Analysis]
17 Midtvedt T. The gut: a triggering place for autism - possibilities and challenges. Microb Ecol Health Dis 2012;23. [PMID: 23990818 DOI: 10.3402/mehd.v23i0.18982] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
18 Berger JM, Rohn TT, Oxford JT. Autism as the Early Closure of a Neuroplastic Critical Period Normally Seen in Adolescence. Biol Syst Open Access 2013;1. [PMID: 24353985 DOI: 10.4172/2329-6577.1000118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
19 Abruzzo PM, Ghezzo A, Bolotta A, Ferreri C, Minguzzi R, Vignini A, Visconti P, Marini M. Perspective Biological Markers for Autism Spectrum Disorders: Advantages of the Use of Receiver Operating Characteristic Curves in Evaluating Marker Sensitivity and Specificity. Dis Markers 2015;2015:329607. [PMID: 26648598 DOI: 10.1155/2015/329607] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
20 Graham SF, Turkoglu O, Yilmaz A, Ustun I, Ugur Z, Bjorndhal T, Han B, Mandal R, Wishart D, Bahado-Singh RO. Targeted metabolomics highlights perturbed metabolism in the brain of autism spectrum disorder sufferers. Metabolomics 2020;16:59. [PMID: 32333121 DOI: 10.1007/s11306-020-01685-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]